We reviewed the ever increasing body of work on the impact of COMT (catechol-o-methyltransferase), a gene associated with risk for schizophrenia, on the efficiency of cognition, working memory, fluid intelligence and attentional control. There is a large body of work, in both humans and non-human primates, which shows the central role of the prefrontal cortex in information processing. We also know that dopamine regulates this information processing and that genetic factors influence the amount of dopamine in the brain. Here, we look at how the COMT polymorphism valine158methionine has helped to characterize various interacting aspects of complexity with relation to genes and cognition. We performed a critical examination of how COMT valine/methionine has been used to develop and validate behavioral and neurophysiological phenotypes. We look at how COMT has been used as a tool in delineating overlapping neural functional systems, and in exploring gene-gene and gene-environmental interactions. Lastly, how COMT is used in understanding gene affects on cognition are regulated by environmental, demographic and developmental influences. It has been well established that the amount of dopamine available in the prefrontal cortex is directly associated with the COMT val/met polymorphism. This affect is seen in differences in prefrontal physiology and information processing of COMT val/val carriers versus COMT met/met carriers. We have determined, by examination of COMTs role in schizophrenia, the COMT gene nicely illustrates the strategy of using genetic phenotype associations to examine neurobiological hypotheses regarding both healthy and impaired brain function. We will continue our work in this area, as there is still much to uncover about the association between genes and cognition and how to apply this knowledge in the field of behavioral medicine and treatments for schizophrenia.

Project Start
Project End
Budget Start
Budget End
Support Year
15
Fiscal Year
2009
Total Cost
$88,038
Indirect Cost
Name
U.S. National Institute of Mental Health
Department
Type
DUNS #
City
State
Country
Zip Code
Dickinson, Dwight (2014) Zeroing in on early cognitive development in schizophrenia. Am J Psychiatry 171:9-12
Morita, Yukitaka; Callicott, Joseph H; Testa, Lauren R et al. (2014) Characteristics of the cation cotransporter NKCC1 in human brain: alternate transcripts, expression in development, and potential relationships to brain function and schizophrenia. J Neurosci 34:4929-40
Gomar, Jesus J; Gordon, Marc L; Dickinson, Dwight et al. (2014) APOE genotype modulates proton magnetic resonance spectroscopy metabolites in the aging brain. Biol Psychiatry 75:686-92
Dickinson, Dwight; Straub, Richard E; Trampush, Joey W et al. (2014) Differential effects of common variants in SCN2A on general cognitive ability, brain physiology, and messenger RNA expression in schizophrenia cases and control individuals. JAMA Psychiatry 71:647-56
Schaefer, Jonathan; Giangrande, Evan; Weinberger, Daniel R et al. (2013) The global cognitive impairment in schizophrenia: consistent over decades and around the world. Schizophr Res 150:42-50
Hashimoto, Ryota; Ikeda, Masashi; Ohi, Kazutaka et al. (2013) Genome-wide association study of cognitive decline in schizophrenia. Am J Psychiatry 170:683-4
Tost, Heike; Alam, Tajvar; Geramita, Matthew et al. (2013) Effects of the BDNF Val66Met polymorphism on white matter microstructure in healthy adults. Neuropsychopharmacology 38:525-32
Gold, James M; Dickinson, Dwight (2013) ""Generalized cognitive deficit"" in schizophrenia: overused or underappreciated? Schizophr Bull 39:263-5
Kunii, Y; Hyde, T M; Ye, T et al. (2013) Revisiting DARPP-32 in postmortem human brain: changes in schizophrenia and bipolar disorder and genetic associations with t-DARPP-32 expression. Mol Psychiatry :
Wallwork, R S; Fortgang, R; Hashimoto, R et al. (2012) Searching for a consensus five-factor model of the Positive and Negative Syndrome Scale for schizophrenia. Schizophr Res 137:246-50

Showing the most recent 10 out of 24 publications